共 26 条
[1]
Nehra A(2015)Peyronie's disease: AUA guideline J Urol 194 745-753
[2]
Bilgutay AN(2015)Peyronie's disease: a review of etiology, diagnosis, and management Curr Sex Health Rep 7 117-131
[3]
Pastuszak AW(2013)Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies J Urol 190 199-207
[4]
Gelbard M(2019)Intralesional collagenase clostridium histolyticum causes meaningful improvement in men with Peyronie’s disease: results of a multi-institutional analysis J Urol 201 777-782
[5]
Hellstrom WJG(2018)Plaque calcification: an important predictor of collagenase clostridium histolyticum treatment outcomes for men with Peyronie’s disease Urology 119 109-114
[6]
Wymer K(2018)Predictors of treatment success after collagenase clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study BJU Int 122 680-687
[7]
Cocci A(1993)Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study J Urol 149 56-58
[8]
Gelbard MK(2015)Clinical efficacy of collagenase clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies BJU Int 116 650-656
[9]
Lipshultz LI(2006)An analysis of the natural history of Peyronie's disease J Urol 175 2115-2118
[10]
Mulhall JP(2013)Clinical evaluation of treatment of Peyronie’s disease with collagenase clostridium histolyticum: analysis of penile curvature deformity by duration of disease and plaque calcification J Urol 189 e681-e682